Page last updated: 2024-11-13

petrosaspongiolide m

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

petrosaspongiolide m: isolated from the caledonian marine sponge Petrosaspongia nigra; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73407439
MeSH IDM0303268

Synonyms (1)

Synonym
petrosaspongiolide m

Research Excerpts

Overview

Petrosaspongiolide M (PM) is an anti-inflammatory marine metabolite. It displays a potent inhibitory activity toward group II and III secretory phospholipase A(2) (PLA(2)) enzymes.

ExcerptReferenceRelevance
"Petrosaspongiolide M (PM) is an anti-inflammatory marine metabolite that displays a potent inhibitory activity toward group II and III secretory phospholipase A(2) (PLA(2)) enzymes. "( Molecular basis of phospholipase A2 inhibition by petrosaspongiolide M.
Casapullo, A; Dal Piaz, F; Gomez-Paloma, L; Marino, G; Pucci, P; Randazzo, A; Riccio, R, 2002
)
2.01
"Petrosaspongiolide M (PT) is a potent secretory phospholipase A(2) inhibitor and anti-inflammatory agent. "( Inhibition of the NF-kappaB signaling pathway mediates the anti-inflammatory effects of petrosaspongiolide M.
Alcaraz, MJ; Gomez-Paloma, L; PayĆ”, M; Posadas, I; Randazzo, A; Terencio, MC, 2003
)
1.98
"Petrosaspongiolide M is a new inhibitor of secretory PLA2 in vitro and in vivo, with anti-inflammatory properties in acute and chronic inflammation."( Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
Alcaraz, MJ; Garcia-Pastor, P; Gomez-Paloma, L; Paya, M; Randazzo, A, 1999
)
1.41
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (7.69)18.2507
2000's8 (61.54)29.6817
2010's4 (30.77)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.71 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.35 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]